| MARKET ALERT – Wall Street Rumblings – Issue #CLXXIII dated March 30, 2014 by Ray DirksPosted on admin on March 30, 2014 // Leave Your Comment
Market Alert – Wall Street Rumblings Up, Down, and Around Wall Street – March 30, 2014 -
Issue #CLXVIII – featuring RAYDIRKS Research – with Ray Dirks and his team of
Money Managers and Security Analysts – in association with the internationally followed
Web Sites www.CorporateProfile.com and www.CPreports.com, where Fashion meets Finance, and where Stocks meet Blonds.
Last week was a tough time for the U.S. stock market, which fell about 0.5% on average,and the weakest areas were biotech and technology stocks, particularly small cap shares.
To quote from “The Trader” column in tomorrow’s Barron’s, the Dow Jones Business and
Financial Weekly, “It was a good week to be out of U.S. stocks as broad market indexes here gave up ground. That was in marked contrast to major markets around the world, which posted solid rises. After American stocks smoked foreign equities last year, this was a rare week of role reversal.
In sympathy with overseas equities , the largest U.S. companies – which tend to get a good chunk of their sales from international sources – did better. Small-company stocks, typically more domestically focused, fell sharply. Among them, technology and biotech did especially poorly.
World equities, not including the U.S., were up 1.8%; German stocks rose nearly 3%, Japan was up 1.5%.
On these shores, the Standard & Poor’s 500 index dropped nine points, or 0.5%, to 1,858. The Nasdaq Composite index lost 121 points, or 2.8%. to 4,156. The Russell 2000 small-company index dropped 42 points, or 3.5%, to 1,152. Only the Dow Jones Industrial Average gained, up 0.1%, 20 points, to 16,323.
With the first quarter about to end, the S&P 500 is essentially flat, a far cry from the 10% rise in the same year-ago period. The bond market continues to confound. Though many have expected interest rates to rise since the Fed announced the tapering in mid-December, bond prices are higher and rates lower. The lower end of the Treasury yield curve has flattened a little bit, suggesting bond investors don’t see much in the way of U.S. economic growth. Maybe that’s why some have put their money to work overseas.”
The sell-off provides investors and readers of this article an opportunity for the Rumblings readers with to buy many our Favorite Stocks for 2014 at very attractive prices currently. Ray Dirks and his team are listing below ten of these stocks – with very big upside potential, in our opinion – followed by some paragraphs from recent articles published in the press or on the Internet which discusses these companies in a way that provides reasons for visualizing higher prices for their stocks this year.
Company Name Stock Symbol March 28 Price Price Range – 12 Months
Fusion Telecommunications International FSNN $ 0.10 $ 0.18 - $ 0.06
Victory Electronic Cigarettes ECIG $13.48 $ 60.00 – $
Neuralstem CUR $ 3.88 $ 4.80 – $ 1.00
Cover-All Technologies COVR $ 1.43 $ 1.80 – $ 1.00
Oramed Pharmaceuticals ORMD $ 10.56 $ 32.00 -$ 5.00
ProMetic Life Sciences PFSCF $ 1.09 $ 1.49 $ 0.30
Arabian-American Development ARSD $ 10.42 $ 13.17 -$ 7.07
AFLAC AFL $ 62.66 $ 67.62 -$48.04
BioTime BTX $ 3.11 $ 4.82 – $3.01
Hartford Financial Services HIG $ 34.88 $ 36.76- 24.67
Fusion (FSNN) at $0.10 is the Number One choice of Wall Street Rumblings by Ray Dirks and his team of Money Managers and Security Analysts for Capital Appreciation in the Short Term (3-6 months) and the Long Term (6 months to 2 years). In summary, Rumblings thinks Fusion will sell at $1.00 within 3 to 6 months – by the 4th of July – and FSNN will sell at $3.00 per share within 6 months to 2 years – by January 15, 2015. !! This reflects the fact that Fusion – one of the leading companies in the cloud with revenues well over $100 million annually and EBITDA of approximately $15 million annually currently – is by far the fastest growing cloud company with the strongest position in the United States in the health care vertical space, which Ray Dirks and his team thinks will grow by 50 % to 75% per year in revenues and EBITDA for at least the next five years. This will be reflected soon in the FSNN stock price because Fusion will be listed on the national Nasdaq market before July 4th – after reverse-splitting its stock. Fusion’s outstanding management team is led by Chief Executive Officer Matthew Rosen, and the company has the best Board of Directors and Advisory Board that we know of in the Technology and the Cloud Spaces. Fusion recently completed a $60 Million financing, and yet the fully diluted market capitalization is less than $70 Million. Within 5 years Rumblings thinks FSNN will sell at a $60 Billion Market Capitalization, about 100 times the current Market Capitalization. !!!
Victory Electronic Cigarettes (ECIG) at $13.48 is the Number Two choice of Rumblings for short and long term capital appreciation. In the United States alone, the E-Cigarette market is projected by industry observers to grow from less than $3 Billion annually today to more than $300 Billion in 5 to 10 years, and the E-Cigarette market worldwide is projected to reach $700 Billion. Victory Electronic Cigarettes, which went public through Goldman, Sachs and other major underwriters less than a year ago, has become the leading E-Cigarette Brand in the U.S., aided by key acquisitions, and ECIG is emerging also as the leading E-Cigarette brand in Western Europe. ECIG has recently achieved annualized revenues of over $100 Million – with sales in major outlets in all 50 states in the U.S. . Market Capitalization is $700 Million, and Rumblings thinks that ECIG stock will climb by 15 times within 2 years – to a market capitalization of over $10 Billion. !!
Neuralstem (CUR) at $3.88 is a biotechnology company that focuses on the development and commercialization of treatments for central nervous system disease based on human neuralstem cells and the use of small molecule compounds. CUR has recently reported that preliminary results in Phase I and Phase 2 trials now underway for the treatment of ALS (Lou Gehrig’s Disease) and also for the treatment of injuries to the spine, have shown results never before achieved. Market Capitalization is only $335 Million currently, and Rumblings thinks CUR will sell at $10.00 within a year, or 3 times the current market price.
Cover-All Technologies (COVR) at $1.43 is a rapidly growing software-based technology company that is on the verge of making significant bottom-line profits as a result of its success in attracting as clients a number of insurance companies, some of which are household names. The Market Capitalization of COVR is only $42 Million and Rumblings thinks that Cover-All Technologies common stock will sell at $7.00 within a year, or 5 times the current market price.
Oramed Pharmaceuticals (ORMD) at $10.56 is a pharmaceutical company engaged in the development of orally ingestible capsules or pills for the treatment of type-1 diabetes and polypeptides. This has the potential to improve compliance and quality of life by reducing injections for diabetes patients. The Market Capitalization of ORMP is only $103 Million, and Rumblings thinks that Oramed will sell at $40.00 within a year, or about 4 times the current price.
ProMetic Life Sciences (PFSCF) at $1.09 is a bio-pharmaceutical company engaged in the research, development, manufacturing and marketing of small molecule therapeutics and protein technologies for various medical needs in the fields of cancer, anemia, fibrosis, neutropenia, and auto-immune related diseases, as well as certain nephropathies. ProMetric Life Sciences has a Market Capitalization of $550 Million, and Rumblings thinks that PFSCF common stock will sell at $4.50 within a year, or 4 times the current price.
Arabian American Development (ARSD) at $10.92 manufactures – in the U.S.- specialty petrochemical products (a very profitable and rapidly growing business) and also has a significant (roughly 50%) interest in the largest gold, copper, zinc,and silver mine in Saudi Arabia, which will be entering its production phase within a year. The Market Capitalization is only $264 Million, and Rumblings thinks that ARSD will sell at $45.00 per share within a year, or 4 times its current market price.
AFLAC (AFL) at $62.66 is the largest seller of specialty health insurance plans in Japan, and AFL has also become a leader in selling supplemental life and health insurance in the United States. The Market Capitalization is $29 Billion and earnings per share are around $6.50 per share, so the common stock of AFLAC is very cheap currently, Rumblings thinks that AFL common stock will sell at $125.00 per share within a year, or 2 times the current price.
BioTime (BTX) at $3.11 is a bio-technology company focusing primarily on research and development in the field of regenerative medicine, which refers to therapies related to embryonic stem cell and induced pluripotent stem cell technology designed to rebuild stem cell and tissue function loss due to degenerative disease or injury. The Market Capitalization is only $276 Million, and Rumblings thinks that BTX common stock will sell at $10.00 per share within a year, more than 3 times the current price.
Hartford Financial Services (HIG) at $34.88 is one of the largest and most successful property and casualty insurance companies in the United States, and HIG is very cheap in relation to its book value, and its potential earning power of $5.00 or better in a good year. The Market Capitalization of Hartford Financial Services is $15.6 Billion, and Rumblings thinks that HIG will sell at $70.00 per share within a year, or 2 times its current market price.
Ray Dirks and his team of Money Managers and Security Analysts suggest that readers/investors place no more than 1% of the money they place in common stocks in any one security. It’s best to diversify. !
Disclosure:
The information contained in this Report contains forward-looking statements relating to the developments of the featured company’s products, services and future operating results or the future of the market. Statements contained in writing or in interviews are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. The words “believe,”, “expect,” “intend,” “anticipate,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking.
These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect performance include, but are not limited to, those factors that are discussed in each Company’s most recent reports and/or registration statements filed with the Securities and Exchange Commission. Visitors to this Internet Site are cautioned not to place undue reliance on these forward-looking statements. These statements have not been independently verified by the officers, directors or employees of Corporate Profile, LLC .com.
The information on this Internet Site has been submitted by journalists and analysts or provided by the companies contained herein or other sources believed to be reliable. Corporate Profile, LLC has not independently verified the information provided to it by third parties. Each individual should perform his or her own independent analysis before investing. The information contained herein is neither an offer nor a solicitation to buy any of the securities of the companies contained herein. Investing in securities is speculative and contains a high element of risk
================================================================
RAYMOND DIRKS THE CONMAN AND CRIMINALS CHOICE TO BE PAID ANALYST TO TOUT STOCKS
ELLIOT SPITZER NEEDS HELP IN UNCOVERING THE PAID FRAUDULENT SCUM THAT CALL THEMSELVES ANALYSTS. THIS THREAD IS DEDICATED TO RAYMOND DIRKS. ALL INFORMATION POSTED TO BE FORWARDED TO ELLIOT SPITZER AND THE NASDAQ WHICH IN THE CASE OF RAYMOND L. DIRKS CONTINUES TO LOOK THE OTHER WAY. IF YOU HAVE AN EXAMPLE OF RAYMOND DIRKS PUFFERY PLEASE POST IT
The Best Coverage Money Can Buy
Bloomberg Personal Finance,
April, 2000
Investors sometimes assume that if a stock is covered by one or more brokerage houses, that means they have a fundamentally favorable opinion of the stock's merits. That isn't necessarily so.In the extreme case, brokerage firms (mainly small ones) accept financial inducements to provide coverage. For example, in 1998 J-Bird Music Group (JBRD) retained Security Capital Trading (run by the well-known but controversial analyst Ray Dirks) for advisory services. Security Capital issued a favorable report on J-Bird, which provided Security Capital with 500,000 shares of restricted stock. The existence of those shares was not mentioned in the report. Perhaps you think that such arrangements are a little less than arm's length. But that is only one gross form of the Wall Street coverage game. There are many other forms. Companies that dole out stock offerings to major investment-banking firms have certain (often unspoken) expectations about research coverage. They expect: (1) that the investment banking firm will cover the stock, (2) that it will say favorable things about it, and (3) that it will provide a "booster shot" of favorable coverage not long after the stock offering. These expectations apply to any offering, but especially to the first one, the initial public offering. Brokerage houses that violate these norms often find themselves frozen out of a company's next offering, a fate worse than death these days! --JD
Ray Dirks of Security Capital Trading, Inc. Recommends J-Bird Music Group (OTC Bulletin Board: JBRD) as Strong Internet Growth Stock
WILTON, Conn., July 21 /PRNewswire/ -- J-Bird Music Group, Ltd. todayannounced that it has established an investment banking relationship with thefirm of Security Capital Trading, Inc. Ray Dirks, the well-known securitiesanalyst, is currently recommending the purchase of J-Bird stock, the Wilton,Connecticut-based Internet record label. This comes on the heels of J-Bird'srecent announcement of the signing of rock legend Billy Squier, who has soldmore than 15 million records during his illustrious career.In a 14-page analysis of the company's two-year history and prospects,made public on July 13, 1998 by Security Capital Trading, Inc., J-Bird Recordsis recognized as a company with "huge potential that has not yet beendiscovered by the investment community." The study concludes with therecommendation that "shares of J-Bird are recommended for purchase by veryaggressive, long-term growth oriented investors who are seeking a low-pricedstock that offers a considerable upside potential.""We are extremely impressed with the innovative game plan of the company'sdynamic leader, Jay Barbieri," said Dirks of Security Capital Trading, Inc."The size and growth prospects of the CD segment of the recorded music marketbeing addressed by the company makes use of the Internet to gain exposure fornew artists, as well as formerly successful ones, and takes advantage of thealready well entrenched recording industry marketing and distributionchannels.""Although many Internet-based companies are currently celebratingtremendous success, I believe that continued growth is only inevitable forthose companies like J-Bird that own its content," said J-Bird Music Group'spresident and CEO, Jay Barbieri. "By having this recommendation, from RayDirks, it marks yet another step in our efforts to move toward expanding ourimpact on the recorded music marketplace."In addition to its own record label, web site(http://www.j-birdrecords.com) and 24-hour Web radio station, J-Bird MusicGroup, founded in 1996, has established a relationship with AT&T's a2b musicservice, whose web site will soon permit customer access to J-Bird's artistmusic. J-Bird has also entered into a national distribution agreement withNavarre Corporation, one of the United States' largest distributors of musicto retail outlets. Their 50,000 accounts include Best Buy, Blockbuster,Borders, Circuit City, HMV and Tower.The full report and analysis can also be accessed athttp://www.raysearch.com.SOURCE J-Bird Music Group, Ltd.
Web Site: j-birdrecords.com
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Copyright © 1996-2002 PR Newswire Association Inc. All Rights Reserved.
A United Business Media company.
FURTHER VINDICATION!!
SEC v. Sky Capital LLC a/k/a Granta Capital LLC, Ross Mandell, Stephen Shea, Adam Harrington Ruckdeschel, Arn Wilson, Michael Passaro and Robert Grabowski, Civil Action No. 09-CV-6129 (SDNY) (PAC)
U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 21120 / July 8, 2009
SEC v. Sky Capital LLC a/k/a Granta Capital LLC, Ross Mandell, Stephen Shea, Adam Harrington Ruckdeschel, Arn Wilson, Michael Passaro and Robert Grabowski, Civil Action No. 09-CV-6129 (SDNY) (PAC)
SEC Charges Broker-Dealer, Founder, Executive and Registered Representatives in Multi-Million Dollar Transatlantic Stock Manipulation Scheme
On July 8, 2009, the Securities and Exchange Commission (Commission) filed a civil injunctive action in the United States District Court for the Southern District of New York charging a New York based broker-dealer, Sky Capital LLC a/k/a Granta Capital LLC (referred to herein as Sky Capital) for using fraudulent boiler room tactics between September 2002 and November 2006 to raise more than $61 million from investors in two related companies — Sky Capital Holdings Ltd. and Sky Capital Enterprises, Inc. (the Sky Entities). The Commission also charged Sky Capital's founder, former President and CEO, Ross Mandell, the firm's former COO, Stephen Shea, and four registered representatives, Adam Harrington Ruckdeschel, Arn Wilson, Michael Passaro, and Robert Grabowski, for orchestrating and participating in the fraudulent scheme designed to fraudulently induce numerous individuals to invest in the Sky Entities.
According to the Commission's complaint, Mandell orchestrated the fraudulent scheme with the assistance of Shea and the other defendants. According to the complaint, Mandell directed Sky Capital brokers to make material misrepresentations, and fail to disclose material information, to induce their Sky Capital customers to purchase stock in the Sky Entities. Mandell also personally made material misrepresentations to his customers. Additionally, the defendants implemented and enforced a "no-net sales" policy, which had the effect of preventing investors from selling their Sky Entities' stocks that were otherwise publicly traded on the Alternative Investment Market of the London Stock Exchange. The no-net sales policy had the effect of artificially inflating the price of the Sky Entities' stocks. Moreover, as a result of the "no-net sales" policy, which the defendants did not disclose to their customers, numerous Sky Capital investors were unable to sell their shares in the Sky Entities before trading in those stocks was suspended thereby rendering the investments worthless.
The SEC's complaint further alleges that the fraudulent scheme was extremely profitable for the defendants. Between 2002 and 2006, Sky Capital raised over $61 million from investors in the U.S. and the U.K. Mandell used the investor funds to subsidize his own lifestyle, including using investor funds for various personal expenses, including first-class travel, five-star hotel stays, expensive meals, adult entertainment, and child-care expenses. Mandell also used investor funds to richly compensate the other individual defendants by paying them hefty undisclosed commissions and giving them other perks.
The SEC's complaint charges each of the defendants with violations of Section 17(a) of the Securities Act of 1933, and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The complaint also, in the alternative, charges Shea with aiding and abetting the other defendants' violations of Section 10(b) of the Exchange Act and Rule 10b-5 thereunder. Additionally, the SEC's complaint charges Sky Capital with violating Section 15(c) of the Exchange Act, and Mandell with aiding and abetting Sky Capital's violation of Section 15(c) of the Exchange Act. The complaint seeks a final judgment permanently enjoining the defendants from future violations of the above provisions of the federal securities laws, ordering them to disgorge their ill-gotten gains plus prejudgment interest, and ordering them to pay civil penalties. The complaint also seeks to permanently prohibit Mandell from acting as an officer or director of any registered public company.
SEC Complaint
sec.gov
--------------------------------------------------------------------------------
Home | Previous Page Modified: 07/08/2009
====================================================================
Ray Dirks latest SCAM promoted by Gene Marcial formerly of Businessweek who promoted Dirks in his columns back then also.
========================================================================
About
CPreports.com is a one stop resource for the hottest stock news and stock picks from financial gurus and analysts.
CPreports.com provides access to cutting edge investment newsletters and small cap reports, as well as real-time updates from the latest up-and-coming small and microcap companies through its sister site, www.CorporateProfile.com. Be informed with CPreports.com! Featured on CPreport.com is Wall Street legend Ray Dirks’, market commentary column.
Ray Dirks
Ray Dirks came to Wall Street with Goldman, Sachs & Co. in 1963 where he was established as the leading insurance stock analyst dealing with institutional investors and high -net worth investors both in the U.S. and internationally.
In 1973 Ray uncovered the biggest Ponzi scheme of the 20th century, the Equity Funding fraud. Equity Funding Corporation, listed on the New York Stock Exchange, had been widely touted as the fastest -growing large insurance company in the country, but Ray’s research, which he conveyed to The Wall Street Journal and Barron’s, exposed the fraud in less than 30 days. Over 20 officers and accountants and lawyers went to jail, However, as the man who blew the whistle on this Ponzi scheme, Ray himself was charged by the SEC with civil fraud and was forced to battle the Securities and Exchange Commission all the way to The Supreme Court where Ray won the landmark 1983 decision on Inside Information violations, known widely as The Dirks Decision.
Over the years Ray has expanded his stock market research to include Healthcare Stocks and Special Situations, including Heavily Shorted Stocks, an area where Ray became widely known as the founder and principal researcher of The ShortBusters Club.
Ray has written two books,” The Great Wall Street Scandal” and “Heads You Win, Tails You Win”, published by McGraw-Hill and Bantam Books respectively. He continues to provide research to institutions and individuals, and he manages money for some individual investors.
Gene Marcial
Gene G. Marcial was Business Week’s “Inside Wall Street” columnist for 28 years until Dec. 2, 2009, when Bloomberg took over the magazine. He is also a former columnist at the Wall Street Journal, where he wrote the “Heard on the Street” column and the “Abreast of the Market” column for more than seven and a half years.
Marcial now writes the “Street Beat” column for Forbes and continues to be one of the most influential stock columnists, closely watched by investors and corporate executives alike. When he was writing the column for Business Week, a favorable mention often resulted in a jump in the stock price on the first trading day the magazine became available to the public.
“It is well understood that trading in the stock market is full of risks. But if you are ready to take the plunge, I guarantee that there will be a time when being familiar with Gene Marcial’s 7 Commandments of Stock Investing will be extremely important. Over the years, I have followed many of the same commandments.” Those were the words of a legendary investor Carl Icahn, Chairman of Icahn Associates, in his endorsement of Marcial’s book, “Gene Marcial’s 7 Commandments of Stock Investing,” published in 2008 by FT (Financial Times) Press.
Marcial’s first book was “Secrets of the Street, the Dark Side of Making Money,” published in 1995 by McGraw-Hill Publishing. It was one of the early books that told all about the rampant insider trading activity on Wall Street, where Marcial argues the financial system, the very heart of the capitalistic system, breeds greed, corruption, and irresistible temptation. In its review of the book, Newsweek said: “A frightening look at how inside trading remains widespread years after Ivan Boesky’s parole.” That was in 1995. So much more insider trading scandals have captured headlines since then.
Marcial received an undergraduate degree in Journalism from the Santo Tomas University in Manila before studying law at the New York Law School and receiving a graduate degree in Political Science from New York University.
Additional reports contributed by:
Rob Goldman
Rob Goldman has 20 years of investment and company research experience as a senior research analyst and as a portfolio and mutual fund manager. During his tenure as a sell-side analyst, Rob was a senior member of Piper Jaffray’s Technology research team covering Israeli Technology and Communications Software. Prior to joining Piper, Rob led Josephthal & Co.’s Washington-based Emerging Growth Research Group as well as the Firm’s Israeli research team. In addition to his sell-side experience Rob served as Chief Investment Officer of a boutique investment management firm and Blue and White Investment Management, where he managed Small Cap Growth portfolios and The Blue and White Fund.
Additional Reports by:
Timothy Sykes
Timothy Sykes is the #1 ranked trader out of 60,000+ on Covestor and the CEO and Co-Founder of Profit.ly, a community of over 15,000 traders who shares their trades openly and Investimonials.com, a financial product review website with nearly 20,000 original reviews on brokers, newsletters, websites and everything else financial. Follow him on Twitter @timothysykes and for more info go to: to profit.ly and investimonials.com
Additional reports contributed by:
Brad Greenspan
Brad Greenspan is a successful Internet entrepreneur and investor who has facilitated numerous US & Asian investment and business transactions. He is the Founder of social networking giant MySpace and he is regarded as one of the pioneers of the social networking sector. As the Former CEO and Chairman of eUniverse / Myspace, Brad was primarily responsible for increasing the value of the organization from zero (when it was launched in 1999) to $580 million when it was acquired by Rupert Murdoch’s News Corp. in 2005. Brad’s portfolio of start up and early stage companies has covered a broad range of sectors including: Big Fish Games (gaming), Borba Corporation (neutracuticals), Fluid Music (music), Draths (clean technology). He is also the Founder and Chairman of Broadweb Asia a leading Asian focused online entertainment Company. Brad is also the Founder CEO and Chairman of Live Universe a social networking aggregator
Brad received a BA from UCLA
Additional Reports contributed by:
Len Bogner
Leonard Bogner is President of Bogner Business Associates LLC, a diversified management consulting/financial and public relations firm with unique specialization in the chemicals and allied products industries. Prior for forming his consulting organization in 1994, Mr. Bogner spent more than 20 years on Wall Street as a Senior equities research analyst (mainly at Prudential Securities), where he followed major diversified chemical and micro-cap companies. He was a perennial Institutional Investor All-Star selection and named to the Wall Street Journal “Best Analysts” list in Chemicals in 1989, 1992 and 1993. Prior to joining Wall Street, Mr. Bogner worked as a Senior Editor on McGraw-Hill’s Chemical Week Magazine, where he received the prestigious Jesse H. Neal Award from the American Business Press for articles relating to “Nader vs. DuPont.” He has served as a Director of a public company, worked with a leading private equity group’s Executive Network, and been a guest speaker at many chemical industry company and association forums.
Additional articles contributed by:
Robert Liscouski
Robert Liscouski was appointed by President George W. Bush as the first Assistant Secretary for Infrastructure Protection when the U.S. Department of Homeland Security was founded in 2003 and he served in that position until 2005.
As a former senior executive at the U.S. Department of Homeland Security, Mr. Liscouski is a recognized expert in Homeland Security including Risk Management and Corporate Security; Infrastructure Protection; Protection of U.S. Interests abroad; and National Security. In Infrastructure Protection, his expertise includes Transportation Security, Air Cargo Security, Chemical Security, Soft Targets, and Improvised Explosive Devices.
During his tenure at the U.S. Department of Homeland Security, Mr. Liscouski was responsible for the design, development, implementation and oversight of numerous programs including The Office of Infrastructure Protection Directorate which had a budget of over $500 million in one year.
Prior to joining the U.S. Department of Homeland Security, he was Director of Information Assurance at the Coca-Cola Company and Vice President of the Law Enforcement Division of Orion Scientific Systems.
He is currently a visiting fellow at the Center for Strategic and International Studies, as Washington D.C. based think tank and was a board member of the Intelligence Science Board supporting the Director of the Central Intelligence Agency and the Director of National Intelligence for 12 years. He also serves on the Board of Directors of Implant Sciences, a high technology supplier of systems and sensors for homeland security markets.
Mr. Liscouski is also currently a partner in Secure Strategy Group, LLC, a New York and Washington DC based investment bank dedicated to backing and building market leaders in the security and defense technology sectors. He is also founder and Managing Director of Edge360 an enterprise risk management and technology solutions firm and a founder of Steel City Re, a firm specializing in reputation risk and intangible asset risk management.
He holds an MPA from the Kennedy School of Government, Harvard University and a B.S. in Criminal Justice from the John Jay College of Criminal Justice.
Additional articles Contributed by:
Scott L. Greiper
Mr. Greiper has had a distinguished 15-year career in the security and defense industries as both an equity research analyst and investment banker. He is the founder and President of the Secure Strategy Group, a banking and advisory firm that backs and builds growth companies in the security and defense technology markets. Before this he was a Managing Director at Legend Merchant and Head of the firm’s Convergent Security Group, which provided capital, strategic advisory and M&A services to security and defense technology companies. Previously, Mr. Greiper was a Principal and Senior Equity Analyst at C. E. Unterberg, Towbin, where he published research on public companies in the Global Security industry. He was ranked as one of the top analysts in the sector for the performance of his research and trading recommendations. Mr. Greiper has raised over $300 million in capital for public and private security firms and has completed a range of M&A assignments. He attended the Executive MBA program at Columbia University and holds a B. A. in Economics from The University of Chicago.
Additional articles contributed by:
Dr. William Prather
Dr. Prather has been with Pluristem Therapeutics since 2006. He received his BS in Pharmacy and medical degree from the University of Missouri. Besides holding senior healthcare research positions for a variety of investment banks, Dr. Prather co-founded Panacos, Inc., a public pharmaceutical company
Additional articles contributed by:
Sam Seiden:
As the VP of Education at Online Trading Academy, Sam brings over 15 years of experience in equities, forex, options and futures trading which began when he was on the floor of the Chicago Mercantile Exchange where he facilitated institutional orderflow. He has traded equities, futures, interest rate markets, forex, options, and commodities for his personal interests for years and has educated thousands of traders and investors through seminars and daily advisory services both domestically and internationally. Sam has been involved in the markets since 1991 both on and off the floor of the Chicago Mercantile Exchange. He has served as the Director of Technical Research for two trading firms and regularly contributes articles to industry publications. Sam is known for his trading, technical research, and educational guidance.
In February 2011, Sam won the Forex Best Awards in the categories of Best Educator, Best Educational Content, and Best Webinar from FXstreet.com, the leading independent portal dedicated to providing complete and timely information about the Foreign Exchange (Forex) market.
Additional articles and reports contributed by
R. Jerry Falkner, CFA, President, RJ Falkner & Company, Inc.
RJ Falkner & company, Inc. is an independent investment research and financial communications firm that is focused on small- and micro-cap companies with the potential to significantly outperform the overall stock market over at 12-18 month time frame.
R. Jerry Falkner began his analytical career as a member of the institutional research department with Houston-based Underwood, Neuhaus & Company, Inc. in 1969, shortly after graduating summa cum laude from the University of Houston, where he majored in Economics/Finance. Mr. Falkner’s 14-year tenure with that firm, where he served as a “special situations” analyst and Director of Retail Research, was followed by three years with the research department of Johnson, Lane, Space, Smith & Company (predecessor to Interstate Johnson Lane and Wachovia/IJL) in Atlanta, Georgia.
In February 1986, Mr. Falkner returned to Texas, where he joined Lovett Mitchell Webb & Garrison (LMW&G) as Senior Vice President and Director of Special Situations Research (LMW&G was later acquired by Kemper Financial Services). In 1988, he moved to Florida to establish a research department at Gulfstream Financial Associates (a subsidiary of Kemper Financial). In June 1990, Mr. Falkner and two other executives left Gulfstream and co-founded Southeast Research Partners, Inc., an institutional sales/research boutique headquartered in Boca Raton, Florida.
A Chartered Financial Analyst since 1976, Mr. Falkner is a member of the Austin Financial Analyst Society, the Association for Investment Management and Research (AIMR), the International Chartered Financial Analysts Association, the National Association of Business Economists, and the National Investor Relations Institute. He has been quoted in the Wall Street Journal, the Dow-Jones News Service, Reuters, Bloomberg Business News and other financial media services and trade publications.
Mr. Falkner founded RJ Falkner & Company, Inc. in 1991. He lives and works in Austin, Texas; Crested Butte, Colorado; and Sedona, Arizona.
Additional articles contributed by:
Sharon di Stefano
Sharon di Stefano has spent 20 years as a healthcare analyst, beginning her career at Smith Barney, Harris Upham & Co. specializing in medical devices, pharmaceuticals, healthcare information technology, and biopharmacology. Ms. di Stefano had also served as Senior Venture Officer for the Edison Innovation Fund, implemented through the New Jersey Economic Development Authority that provided funding for early-stage life sciences companies.
Industry experience includes laboratory research for Johns Hopkins Hospital and the Department of Defense. Past speaking and consulting engagements include the creation of a pharmaceutical pipeline database for Blue Cross of California; analysis of diagnostic and treatment trends in Hepatitis B for Synergy Pharmaceuticals; business valuation for Wasserstien Perella; bankruptcy workout for FleetBoston Capital Corporation; valuation of a new 250-company ‘fund of funds’ for AON Corporation.
Ms. di Stefano received a Masters of Science degree, in Business, from Johns Hopkins University in 1986, and a Bachelor of Arts from the University of Delaware in 1984 with a minor in biology.
Additional articles contributed by:
Dr. Karuna Sabnani
Dr. Karuna Sabnani is a Beauty and Natural Medicine Expert. For over 10 years, patients have come to Dr. Sabnani to learn how to get a lean body, restful sleep, restored energy, clear skin, strong digestion and stress reduction. Patients often feel a sense of ease, balance and health within their full lifestyles and demanding careers after following Dr. Sabnani’s suggestions.
Dr. Karuna Sabnani is a graduate of Southwest College of Naturopathic Medicine, an accredited four-year naturopathic medical college. She received her Bachelor of Arts degree in Psychology and English Literature from Mount Holyoke College in Massachusetts. Dr. Sabnani is licensed as a Naturopathic Doctor in the state of California, and is a member of the California Association of Naturopathic Doctors. Dr. Sabnani has practiced in Arizona, California and New York City since 2001. She currently lives in New York City and works with patients both nationally and internationally.
Using Ayurvedic principles and Natural Wisdom, Dr. Sabnani designs a personalized health regime or cleanse, often referred to as a “Health & Beauty Makeover’, specific for the patient’s lifestyle. She uses a creative and inspirational approach. Her goal is for her patients to glow in radiant health.
In addition to her general practice, Dr. Sabnani blogs for the Huffington Post and is the health and beauty advisor to IMAN Cosmetics. She is also a part of Illumé, a unique image consulting and wellness service that re-interprets the concept of personal styling.    
© 2010 CP Reports · Disclaimer · Subscribe: Posts Comments · Designed by Theme Junkie · Powered by WordPress |
|
